These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 15006833)
41. Poor oral health and coronary artery disease: Association or causality? Bauersachs J; Berliner D Eur J Prev Cardiol; 2018 Apr; 25(6):596-597. PubMed ID: 29488812 [No Abstract] [Full Text] [Related]
43. Spectrum of Fibrotic Lung Diseases. Karim F; van Laar J; van Hagen M N Engl J Med; 2020 Dec; 383(25):2485. PubMed ID: 33326732 [No Abstract] [Full Text] [Related]
44. Spectrum of Fibrotic Lung Diseases. Salvati L; Palterer B; Parronchi P N Engl J Med; 2020 Dec; 383(25):2485. PubMed ID: 33326733 [No Abstract] [Full Text] [Related]
45. Spectrum of Fibrotic Lung Diseases. Reply. Wijsenbeek M; Cottin V N Engl J Med; 2020 Dec; 383(25):2485-2486. PubMed ID: 33326734 [No Abstract] [Full Text] [Related]
46. Is the association between diabetes mellitus and pulmonary fibrosis real? Kumar V; Nawroth PP Nat Rev Endocrinol; 2021 Dec; 17(12):703-704. PubMed ID: 34561670 [No Abstract] [Full Text] [Related]
47. [The fibrotic component of the senile lung]. FAZIO B; BALESTRERI R Arch Maragliano Patol Clin; 1960 Aug; 16():593-603. PubMed ID: 13698468 [No Abstract] [Full Text] [Related]
48. Association between idiopathic pulmonary fibrosis and coronary artery disease: a case-control study and cohort analysis. Kim WY; Mok Y; Kim GW; Baek SJ; Yun YD; Jee SH; Kim DS Sarcoidosis Vasc Diffuse Lung Dis; 2015 Jan; 31(4):289-96. PubMed ID: 25591140 [TBL] [Abstract][Full Text] [Related]
49. Prevalence and impact of coronary artery disease in idiopathic pulmonary fibrosis. Nathan SD; Basavaraj A; Reichner C; Shlobin OA; Ahmad S; Kiernan J; Burton N; Barnett SD Respir Med; 2010 Jul; 104(7):1035-41. PubMed ID: 20199856 [TBL] [Abstract][Full Text] [Related]
50. The prevalence of coronary artery disease in end-stage pulmonary disease: is pulmonary fibrosis a risk factor? Izbicki G; Ben-Dor I; Shitrit D; Bendayan D; Aldrich TK; Kornowski R; Kramer MR Respir Med; 2009 Sep; 103(9):1346-9. PubMed ID: 19362458 [TBL] [Abstract][Full Text] [Related]
51. Identification and treatment of comorbidities in idiopathic pulmonary fibrosis and other fibrotic lung diseases. King C; Nathan SD Curr Opin Pulm Med; 2013 Sep; 19(5):466-73. PubMed ID: 23912191 [TBL] [Abstract][Full Text] [Related]
52. A multidimensional index and staging system for idiopathic pulmonary fibrosis. Ley B; Ryerson CJ; Vittinghoff E; Ryu JH; Tomassetti S; Lee JS; Poletti V; Buccioli M; Elicker BM; Jones KD; King TE; Collard HR Ann Intern Med; 2012 May; 156(10):684-91. PubMed ID: 22586007 [TBL] [Abstract][Full Text] [Related]
53. Genome-wide assessment of shared genetic landscape of idiopathic pulmonary fibrosis and its comorbidities. Yang Y; Sheng YH; Carreira P; Wang T; Zhao H; Wang R Hum Genet; 2024 Aug; ():. PubMed ID: 39103522 [TBL] [Abstract][Full Text] [Related]
54. Biological Age, Chronological Age, and Survival in Pulmonary Fibrosis: A Causal Mediation Analysis. Pugashetti JV; Kim JS; Bose S; Adegunsoye A; Linderholm AL; Chen CH; Strek ME; Flaherty KR; Murray S; Newton CA; Alqalyoobi S; Ma SF; Mychaleckyj JC; Bowler RP; Han MK; Curtis JL; Martinez FJ; Smith JA; Noth I; Oldham JM Am J Respir Crit Care Med; 2024 Sep; 210(5):639-647. PubMed ID: 38843133 [No Abstract] [Full Text] [Related]